494 related articles for article (PubMed ID: 26454613)
21. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
[TBL] [Abstract][Full Text] [Related]
23. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
[TBL] [Abstract][Full Text] [Related]
24. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
25. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
[TBL] [Abstract][Full Text] [Related]
27. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
[TBL] [Abstract][Full Text] [Related]
29. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
[TBL] [Abstract][Full Text] [Related]
30. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.
Chadha M; Vongtama D; Friedmann P; Parris C; Boolbol SK; Woode R; Harrison LB
Clin Breast Cancer; 2012 Feb; 12(1):57-62. PubMed ID: 22056970
[TBL] [Abstract][Full Text] [Related]
31. Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.
Rovea P; Fozza A; Franco P; De Colle C; Cannizzaro A; Di Dio A; De Monte F; Rosmino C; Filippi AR; Ragona R; Ricardi U
Clin Breast Cancer; 2015 Aug; 15(4):270-6. PubMed ID: 25666079
[TBL] [Abstract][Full Text] [Related]
32. Impact of radiation treatment parameters and adjuvant systemic therapy on cosmetic outcomes after accelerated partial breast irradiation using 3-dimensional conformal radiation therapy technique.
Mellon EA; Sreeraman R; Gebhardt BJ; Mierzejewski A; Correa CR
Pract Radiat Oncol; 2014; 4(3):e159-e166. PubMed ID: 24766690
[TBL] [Abstract][Full Text] [Related]
33. Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up.
Raiyawa T; Lertbutsayanukul C; Rojpornpradit P
J Med Assoc Thai; 2009 Mar; 92(3):390-7. PubMed ID: 19301734
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
[TBL] [Abstract][Full Text] [Related]
35. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
36. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
37. The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation.
Leonard KL; Hepel JT; Hiatt JR; Dipetrillo TA; Price LL; Wazer DE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):623-9. PubMed ID: 22867895
[TBL] [Abstract][Full Text] [Related]
38. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis.
Sanz J; Rodríguez N; Foro P; Dengra J; Reig A; Pérez P; Membrive I; Ortiz A; Codinach M; Algara M
Clin Transl Oncol; 2017 Apr; 19(4):464-469. PubMed ID: 27655367
[TBL] [Abstract][Full Text] [Related]
40. Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique.
Lertbutsayanukul C; Pitak M; Ajchariyasongkram N; Rakkiet N; Seuree F; Prayongrat A
Breast J; 2020 Oct; 26(10):1946-1952. PubMed ID: 32648331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
